English
Back
Download
Log in to access Online Inquiry
Back to the Top

News

$Seres Therapeutics (MCRB.US)$ Reuters· 3 mins ago
FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ Ser-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (Allo-Hsct)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
20K Views
Comment
Sign in to post a comment
    5121
    Followers
    24
    Following
    74K
    Visitors
    Follow
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.